Corcept Therapeutics (CORT) Interest Coverage Ratio Growth (3y) (2013 - 2017)
Corcept Therapeutics (CORT) Interest Coverage Ratio Growth (3y) (2013 - 2017) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
29.25% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
-16.86% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Corcept Therapeutics |
8.35 Bn |
8.01 Bn |
162.02 Mn |
- |
| Date | Value |
|---|
| Jun 30, 2017 |
177.04% |
| Mar 31, 2017 |
55.43% |
| Dec 31, 2016 |
49.36% |
| Sep 30, 2016 |
40.19% |
| Jun 30, 2016 |
31.87% |
| Mar 31, 2016 |
28.08% |
| Dec 31, 2015 |
31.49% |
| Sep 30, 2015 |
26.24% |
| Jun 30, 2015 |
90.01% |
| Mar 31, 2015 |
86.83% |
| Dec 31, 2014 |
85.53% |
| Sep 30, 2014 |
90.42% |
| Jun 30, 2014 |
79.07% |
| Mar 31, 2014 |
79.63% |
| Dec 31, 2013 |
79.83% |
| Sep 30, 2013 |
84.78% |
| Jun 30, 2013 |
83.48% |
